Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Akeso, explained in plain language.
This early-stage study tested the safety and initial effectiveness of two new drugs, AK119 and AK112, given alone or with chemotherapy, for people with a specific type of advanced lung cancer (EGFR-mutant NSCLC) that had stopped responding to standard targeted therapy. The trial …
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC